Zydus Lifesciences Completes Share Buyback: Details Emerge on Capital Reduction and Ownership Shift
Zydus Lifesciences Ltd has completed a significant portion of its share buyback program, resulting in changes to its capital structure. The company utilized a tender offer route for this initiative, which aimed at extinguishing 87,30,158 fully paid-up equity shares.The buyback was executed at a fixed price of INR 1,260/- per Equity Share, targeting an aggregate amount not exceeding INR 1100,00,00,000/- (One Thousand One Hundred Crore). The total amount utilized in the buyback process, excluding transaction costs, amounted to INR 1099,99,980/-, as per post-buyback reports.
The tender offer period saw considerable participation across different categories of shareholders. Of the shares reserved for extinguishment and purchase, a total of 51,454 valid bids were received. This resulted in 81,72,41,315 Equity Shares being validly tendered from eligible shareholders.
Buyback Participation and Shareholding Data
The successful buyback transaction led to several changes in the company’s capital structure. The following data details the pre-buyback shareholding against the total issued capital:| Particulars | Pre Buyback (Shares) | Pre Buyback (Amount in INR) | Post Buyback (Shares) | Post Buyback (Amount in INR) |
|---|---|---|---|---|
| Issued and Fully Paid-Up Share Capital | 100,62,33,990 | 100,62,33,990 | 99,75,03,832 | 99,75,03,832 |
The buyback activity was designed to extinguish 87,30,158 Equity Shares. Shareholders who participated in the purchase of these shares included Zydus Family Trust (63,49,542 shares), Parag Parikh Large Cap Fund (1,69,079 shares), and Kotak Mahindra Trustee Co Ltd A/C KotakNiftyNext50ETF (94,908 shares). The total number of Equity Shares accepted under the buyback amounted to 70,32,275.
Post-Buyback Capital Structure
The shareholding pattern post-buyback shows a slight adjustment in capital structure:| Category of Shareholder | No. of Shares Pre- Buyback | % of Total Pre-Buyback Share Capital | No. of Shares Post Buyback | % of Total Post Buyback Share Capital |
|---|---|---|---|---|
| Promoter and Promoter Group in Concert (A) | 75,46,25,314 | 74.99% | 74,82,73,673 | 75.01% |
| Foreign National/Foreign Corporate Bodies (FNB) | N/A | N/A | 24,92,30,159 | 24.99% |
| Financial Institutions/Banks/Mutual Funds | 11,14,15,893 | 11.06% | N/A | N/A |
| Others and Various Bodies (Corporate Employees etc.) | 6,77,96,550 | 6.74% | N/A | N/A |
The buyback activity was conducted by ICICI Securities Limited.
ZYDUSLIFE Stock Price Movement
As of 12:18 PM, shares of Zydus Lifesciences Limited are edging higher to ₹1068.5, with the stock gaining 0.67% in live trading. The equity sees robust activity, supported by a traded volume of 688,260 as it climbs through this afternoon’s session.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.